Kakatiya Institute Of Oncology Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
- Paid Up Capital ₹ 27.71 Cr
- Company Age 7 Year, 5 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 147.00 Cr
- Satisfied Charges ₹ 8.63 Cr
- Revenue Growth 11623.47%
- Profit Growth -227.42%
- Ebitda -61.19%
- Net Worth -513.58%
- Total Assets -5.63%
About Kakatiya Institute Of Oncology
Kakatiya Institute Of Oncology Private Limited (KIOOPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 February 2018 (Seven years 5 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 27.71 Cr.
The company currently has active open charges totaling ₹147.00 Cr. The company has closed loans amounting to ₹8.63 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Kakatiya Institute Of Oncology Private Limited India is Kirti Goyal as COMPANY SECRETARY. Padmaja Chigurupati and Hara Chigurupati serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
- Apps
Corporate Identity Details
- CIN/LLPIN
U74999TG2018PTC122321
- Company No.
122321
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2018
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Kakatiya Institute Of Oncology Private Limited offer?
Kakatiya Institute Of Oncology Private Limited offers a wide range of products and services, including Diagnostic Imaging & Pathology Labs, Diagnostic Imaging Services, Medical Treatment Services, Radiation Therapy, Medical Surgery Services, Doppler Machine, Portable Color Doppler Ultrasound Scanner.
Who are the key members and board of directors at Kakatiya Institute Of Oncology?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kirti Goyal | Company Secretary | 23-Jan-2024 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Padmaja Chigurupati ![]() | Additional Director | 07-Dec-2023 | Current |
Hara Chigurupati ![]() | Director | 11-Jun-2020 | Current |
Financial Performance of Kakatiya Institute Of Oncology.
Kakatiya Institute Of Oncology Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11623.47% increase. The company also saw a substantial fall in profitability, with a 227.42% decrease in profit. The company's net worth observed a substantial decline by a decrease of 513.58%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Kakatiya Institute Of Oncology?
In 2022, Kakatiya Institute Of Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹147.00 Cr
₹8.63 Cr
Charges Breakdown by Lending Institutions
- Others : 147.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
01 Jun 2024 | Others | ₹11.00 Cr | Open |
18 Oct 2023 | Others | ₹41.00 Cr | Open |
18 Oct 2023 | Others | ₹11.00 Cr | Open |
18 Jul 2022 | Others | ₹11.00 Cr | Open |
22 Aug 2019 | Others | ₹73.00 Cr | Open |
How Many Employees Work at Kakatiya Institute Of Oncology?
Kakatiya Institute Of Oncology has a workforce of 89 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Kakatiya Institute Of Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kakatiya Institute Of Oncology's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.